Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2015 Oct;67(10):1345–1353. doi: 10.1002/acr.22606

Figure 3.

Figure 3

Distribution of Change in CDAI in the TEAR trial between 0 and 6 months according to Patients’ Self-reported Response to Therapy on a 1 (Most Improvement) to 10 (No Improvement) Visual Analog Scale (n=282 patients initiating MTX monotherapy)

Note: solid line drawn at CDAI cutpoint of −12